Pomaglumetad methionil | Interleukin Related interleukin-related.com

Product Name :
Pomaglumetad methionil

Search keywords :
Pomaglumetad methionil

drugId :
null

Target Vo:
Metabotropic glutamate receptor 2

Target Vo Short Name :
GRM2

Moa_Name:
Metabotropic glutamate receptor 2 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Denovo Biopharma Llc

Active Company_Name :
Denovo Biopharma Llc

Active Indication_Name:
Schizophrenia

In Active Indication_Name:
Hepatic Insufficiency

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MyD88 Rabbit mAb Cancer
Certolizumab pegol Protocol
Phospho-MEK4 (Ser80) Antibody: Phospho-MEK4 (Ser80) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to Phospho-MEK4 (Ser80). It can be used for WB,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts